Literature DB >> 2367058

Role of blood groups as prognostic factors in primary breast cancer.

M Costantini1, T Fassio, L Canobbio, M Landucci, M Resasco, F Boccardo.   

Abstract

The role of blood groups as risk factors for breast cancer and their predictive value after radical surgery have been retrospectively evaluated in 315 breast cancer patients. The AB0 group distribution in these breast cancer patients was not significantly different from that of control women. Patients with blood group 0 showed a significantly lower risk of death than those with groups A, B and AB. Moreover, by using Cox's multivariate analysis, blood groups were shown to possess a predictive value independent of other known prognostic factors. These results suggest that also genetic factors could be involved in the pathophysiology of breast cancer growth and need to be further investigated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2367058     DOI: 10.1159/000226839

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  10 in total

1.  ABO blood group and breast cancer incidence and survival.

Authors:  Margaret A Gates; Mousheng Xu; Wendy Y Chen; Peter Kraft; Susan E Hankinson; Brian M Wolpin
Journal:  Int J Cancer       Date:  2012-02-10       Impact factor: 7.396

2.  ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.

Authors:  S Zouine; F Marnissi; N Otmani; M Bennani Othmani; M El Wafi; K Kojok; Y Zaid; N Tahiri Jouti; N Habti
Journal:  Med Oncol       Date:  2016-05-30       Impact factor: 3.064

3.  Do blood groups have effect on prognosis of patients undergoing radical cystectomy?

Authors:  Evren Süer; Cihat Özcan; Ilker Gökçe; Ömer Gülpınar; Cağatay Göğüş; Kadir Türkölmez; Sümer Baltacı; Yaşar Bedük
Journal:  Int Urol Nephrol       Date:  2014-03-28       Impact factor: 2.370

Review 4.  The prognostic value of ABO blood group in cancer patients.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

5.  Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tract.

Authors:  Michael Hejna; Peter Birner; Matthias Preusser; Christiane M R Thallinger; Nina Worel; Reza Asari; Werner Dolak; Rainer Schmid; Sebastian F Schoppmann; Markus Raderer
Journal:  Mol Clin Oncol       Date:  2013-09-12

6.  Prognostic value of ABO blood group in patients with surgically resected colon cancer.

Authors:  X Cao; Z-S Wen; Y-J Sun; Y Li; L Zhang; Y-J Han
Journal:  Br J Cancer       Date:  2014-06-05       Impact factor: 7.640

7.  Blood type, ABO genetic variants, and ovarian cancer survival.

Authors:  Gabriella D Cozzi; Rebecca T Levinson; Hilary Toole; Malcolm-Robert Snyder; Angie Deng; Marta A Crispens; Dineo Khabele; Alicia Beeghly-Fadiel
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

8.  Prognostic value of ABO blood group in a Chinese population in Northwest China region with curatively resected rectal cancer.

Authors:  Jiangpeng Wei; Ying Zhang; Jianyong Zheng; Xiangying Feng; Xiaomin Wang; Kunli Du; Weizhong Wang; Guosheng Wu; Qingchuan Zhao; Daiming Fan; Xiaohua Li
Journal:  J Cancer       Date:  2019-10-21       Impact factor: 4.207

9.  Breast cancer incidence in Greek women in relation to ABO blood groups and Rh factor.

Authors:  Michael Stamatakos; Konstantinos Kontzoglou; Panagiotis Safioleas; Constnatinos Safioleas; Christina Manti; Michael Safioleas
Journal:  Int Semin Surg Oncol       Date:  2009-08-18

10.  Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center.

Authors:  Ning Li; Miao Xu; Chao-Feng Li; Wei Ou; Bao-Xiao Wang; Song-Liang Zhang; Peng-Fei Xu; Cheng Yuan; Qun-Ai Huang; Si-Yu Wang
Journal:  Chin J Cancer       Date:  2015-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.